Path breaking policy changes introduced to make India TB-Free by 2025: Health Sec

Published On 2019-03-26 04:14 GMT   |   Update On 2019-03-26 04:14 GMT
"Universal drug susceptibility testing has been rolled out, shorter and newer treatment regimen has been expanded countrywide. India is moving towards an injection-free regimen. Private sector engagement has been elevated as one of the highest priorities with strengthened regulatory measures, collaborative incentives and scale-up of successful Patient-Provider Support Agency (PPSA) interventions which led to a 35% increase in TB notification from the private sector,"  Union Heath Secretary.

New Delhi:  Health Secretary Preeti Sudan on the occasion of World TB Day on Sunday said with the aim of universal access to free diagnostics and treatment services, path-breaking policy changes have been introduced.


Ministry of Health and Family Welfare here commemorated the World TB Day with a function to mark the occasion and reiterated the commitment to eliminating TB in the country by 2025.


Read Also: IMA calls for unity among stakeholders to eliminate TB by 2025


Ms Sudan presided over the function and stressed on the importance of more sensitive and responsive doctors, paramedics, frontline health workers and community partners while dealing with TB patients.


"The systems of care for TB patients should be patient-centric, and sympathetic to their wellbeing," she emphasised.


She stated that India has been able to free of Polio, Yaws, MNTE due to the sturdy health systems, especially at the primary healthcare levels. She stated that partnerships with all stakeholders hold the key to making India TB-free.


Read Also: IMA all set to fight battle against TB-to increase notification from doctors in private sector


She led the participants of the event to take a pledge to unite together to contribute and support towards making India TB free.


Various presentations made at the event highlighted the key changes introduced in the policy landscape of TB in the country.


India is now closest ever to covering all TB cases with 21.5 lakh new TB patients notified in 2018.


"Universal drug susceptibility testing has been rolled out, shorter and newer treatment regimen has been expanded countrywide. India is moving towards an injection-free regimen. Private sector engagement has been elevated as one of the highest priorities with strengthened regulatory measures, collaborative incentives and scale-up of successful Patient-Provider Support Agency (PPSA) interventions which led to a 35% increase in TB notification from the private sector," she added.


Read Also: Nikshay Poshan Yojana to provide Nutritional Support to TB patients


The Nikshay Poshan Yojana has benefited 15 lakh TB patients for nutrition support with Rs. 240 cores disbursed as DBT since April 2018.


"Institutional system of award for TB free status has been introduced to generate federal competitiveness, motivate and to bring about proactive actions from States and Districts," she added.


"As on date, 15 lakh patients have been initiated in the Fixed Dose Combination (FDC) regime. TB forums at various levels in the states have been formed to remove the stigma and to create awareness about the symptoms of the disease and the free treatment available at the government health facilities. 1180 CBNAAT labs have been made operational throughout the country, along with 4 lakh treatment support centres at the village level. These efforts have resulted in an increase from 25% to 83% in the treatment success rates (2017-2018), and the TB prevalence rates have come down from 29% to 4%," she further stated.


Also present at the event were Shri Sanjeeva Kumar, Additional Secretary & Director General (RNTCP & NACP), and senior officers of the Ministry, representatives from WHO and other development partners, community support organisations.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News